No Detail Found!

Follow-up of Serum Creatine Phosphokinase Levels after Ultrasound Guided Suprainguinal Fascia Iliaca Block with Bupivacaine in Total Knee Arthroplasty Patients: An Observational, Controlled Study

Author(s)
Murat Unal Department of Anaesthesiology and Reanimation, Samsun University, Samsun Training and Research Hospital,Samsun,Turkiye
Nevzat Gumus Department of Anaesthesiology and Reanimation, Samsun University, Samsun Training and Research Hospital,Samsun,Turkiye
Nizamettin Guzel Department of Orthopaedics and Traumatology, Samsun University, Samsun Training and Research Hospital,Samsun,Turkiye
Serkan Tulgar Department of Anaesthesiology and Reanimation, Samsun University, Samsun Training and Research Hospital,Samsun,Turkiye
Ersin Koksal Department of Anaesthesiology and Reanimation, Ondokuz Mayis University,Samsun,Turkiye
Mustafa Suren Department of Anaesthesiology and Reanimation, Samsun University, Samsun Training and Research Hospital,Samsun,Turkiye
Abstract
Objective: To determine the myotoxicity of bupivacaine on muscles after suprainguinal fascia iliaca block for postoperative analgesia in total knee arthroplasty (TKA) patients through changes in serum creatine phosphokinase (CPK) levels during the perioperative period. Study Design: Observational study. Place and Duration of the Study: Postoperative Recovery Room department of Anaesthesiology and Reanimation, Samsun University, Samsun, Training and Research Hospital, Samsun, Turkiye, between December 2022 and February 2023. Methodology: Patients undergoing for the procedure of TKA surgery were recruited. (40 controls and 42 SIFIB groups). Serum CPK levels were evaluated preoperatively, at postoperative 6th hour and 24th hour. Results: From total 82 patients, 42 of them who received SIFIB as a component of multimodal analgesia had serum CPK levels comparable to those in the control group at all time points (p>0.05). While the increase in CPK level atth h6our relative to baseline was signi cant in both groups (p<0.05), only the block group demonstrated a statistically signi cant di erence between the 6th and 24th hours (p<0.05). Conclusion: SIFIB administration did not result in severe bupivacaine-induced myotoxicity in comparison to the control group. SIFIB administration is a safe option when used as part of multimodal analgesia in TKA.
Publication Details
Page(s) 256-261
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Bupivacaine, Creatine Phosphokinase, Regional anaesthesia, Myotoxicity
0

Citations

0

Downloads

70

Views